Lowering homocysteine with B vitamins in patients with coronary artery disease

JAMA

Volumn 300, Issue 24, 2008, Pages 2852-

  Rossi, Gian Paolo ^a   Seccia, Teresa Maria ^a   Pessina, Achille C ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; HOMOCYSTEINE; VITAMIN B COMPLEX;

AMINO ACID BLOOD LEVEL; CARDIOVASCULAR RISK; CAUSE OF DEATH; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; HYPERHOMOCYSTEINEMIA; HYPERTENSION; LETTER; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION; BLOOD; HUMAN; NOTE; RISK FACTOR;

CORONARY ARTERY DISEASE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; RISK FACTORS; VITAMIN B COMPLEX;

EID: 58149229595     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2008.835     Document Type: Letter

References (5)

1. Ebbing M, Bleie Ø, Ueland PM, et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA. 2008;300(7):795-804.
2. Herrmann W, Herrmann M, Obeid R. Hyperhomocysteinaemia: a critical review of old and new aspects. Curr Drug Metab. 2007;8(1):17-31.
3. Rossi GP, Seccia TM, Pessina AC. Homocysteine, left ventricular dysfunction and coronary artery disease: is there a link? Clin Chem Lab Med. 2007;45(12):1645-1651.
4. Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111(14):1777-1783.
5. Cesari M, Zanchetta M, Burlina A, et al. Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high-risk coronary artery disease hypertensives. Arterioscler Thromb Vasc Biol. 2005;25(1):115-121.